U.S. Physical Therapy (USPH) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.75
- Estimate
- $0.84
- Surprise
- -11.2%
- Score at report (before → after)
- 4.8 → 4.5/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
U.S. Physical Therapy (USPH) missed the $0.84 estimate with adjusted EPS of $0.75 — a large 11.2% shortfall. TrendMatrix's engine moved from Buy (Wait) (4.8/10) to Sell at 4.5/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates USPH Sell at 4.4/10.
0 of the last 4 quarters beat the estimate; this quarter's -11.2% surprise compares with a -5.7% four-quarter average. Next scheduled report: 2026-11-04.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Positive momentum
What argues against it
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2)
- Consecutive earnings misses (2)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $84.84
- Price target
- $97.57
- Stop
- $79.86
- Upside to target
- +15.0%
The stock trades at 492.7× trailing but 25.0× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 73 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-09-26 — shown for context, not personalized investment advice.
USPH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $1.25B
- P/E (fwd)
- 25.0
- P/E (ttm)
- 492.7
- 52-week range
- $58.19–$93.50
- Off 52-week high
- 9.3%
- RSI (14)
- 73
- Volume vs avg
- 0.77×
- Score today
- 4.4/10